Concentration and protein composition of circulating immune complexes in the blood of patients with schizophrenia and subjects with positive familial history of disease

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 105, Issue 4, 2005, Pages 55-60

  Mailyan, K R ^a   Boyadzhyan, A S ^a   Sogoyan, A F ^a   Sim, R B ^a   Manukyan, L A ^a  

^a NONE

Author keywords

Circulating immune complexes; Familial history; Protein composition; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD; ELECTROPHORESIS; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; PARANOID SCHIZOPHRENIA;

ADOLESCENT; ADULT; ANTIGEN-ANTIBODY COMPLEX; ELECTROPHORESIS; FEMALE; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA, PARANOID;

EID: 19844377099     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Arakelyan A., Boyajyan A., Hovsepyan M. et al. The application package under "Matlab 5.0" environment for determination of molecular weights of antigens from circulating immune complexes isolated from blood of patients with ischemic stroke. 9th Annual Conference "Electron Microscopy- 2000". Yerevan 2000; 43-44.
2. Bakunts G., Arakelyan A., Boyajyan A., Poghosyan A. Antigen composition of circulating immune complexes in the blood of patients with hemorrhagic strokes. Westnik IAELPS 2001; 6: 42: 1: 97-99.
3. Bartoloni C., Guidi L., Pili R. et al. Assay, isolation and characterization of circulating immune complexes from serum of gastrointestinal cancer, stage III and IV melanoma and chronic inflammatory bowel disease patients. Oncology 1993; 50: 1: 27-33.
4. Cengic M., Rasic S. Importance of determination of circulating immune complexes in systemic lupus erythematosus. Med Arch 2002; 56: 5-6: 267-270.
5. Clynes R., Maizes J.S., Guinamard R. et al. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J Exp Med 1999; 189: 1: 179-185.
6. DeLisi L.E., Ortaldo J.R., Maluish A.E., Wyatt R.J. Deficient natural killer cell (NK) activity and macrophage functioning in schizophrenic patients. Neurol Transmission 1983; 58: 1-2: 99-106.
7. Digeon M., Laver M., Riza J., Bach J.F. Detection of circulating immune complexes in human aorta by simplified assays with polyethylene glycol. J Immunol Methods 1977; 16: 2: 165-183.
8. 2- glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels. Lupus 1999; 8: 2: 116-120.
9. Haeney M. An introduction to allergic disease. J R Coll Physicians Lond 1985; 19: 3: 147-153.
10. Hiepe F., Apostoloff E., Doring E. et al. Circulating immune complexes and age. ZFA 1982; 37: 4: 227-231.
11. Jager L., Hermann D.Z. Significance of the immune complex reaction in internal medicine. Gesamte Inn Med 1980; 35: 2: 49-56.
12. Jans H., Dybkjaer E., Halberg P. Circulating immune complexes in healthy persons. Scand J Rheumatol 1982; 11: 4: 194-198.
13. Kaminska T., Szuster-Ciesielska A., Wysocka A. et al. Serum cytokine level and production of reactive oxygen species (ROS) by blood neutrophils from a schizophrenic patient with hypersensitivity to neuroleptics. Med Sci Monit 2003; 9: 7: CS 71-75.
14. Kolyaskina G.I., Burbaeva O.A., Tsutsulkovskaya M.Ya. Circulating immune complexes and autoantibodies in schizophrenia. Schizophr Res 1999; 36: 1-3: 106.
15. Lacroix-Desmazes S., Kaveri S.V., Mouthon L. et al. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods 1998; 216: 1-2: 117-137.
16. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 259: 680-685.
17. Levy-Soussan P., Berneman A., Poirier M.F. et al. Differences in the natural autoantibody patterns of patients with schizophrenia and normal individuals. J Psychiat Neurosci 1996; 21: 2: 89-95.
18. Linnanmaki E., Leinonen M., Mattila K. et al. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993; 87: 4: 1130-1133.
19. Mackay I.R., Water J.V., Gershwin M.E. Autoimmunity: Thoughts for the milenium. Clin Rev Allergy Immunol 2000; 18: 1: 87-117.
20. Maidment B.W. Jr., Papsidero L.D., Nemoto T., Chu T.M. Recovery of immunologically reactive antibodies and antigens from breast cancer immune complexes by preparative isoelectric focusing. Cancer Res 1981; 41: 3: 795-800.
21. Maury C.P., Teppo A.M. Demonstration of tissue 90 kD glycoprotein as antigen in circulating IgG immune complexes in dermatitis herpetiformis and coeliac disease. Lancet 1984; 2: 8408: 892-893.
22. Maury C.P., Teppo A.M. Immunological abnormalities in massive cutaneous hyalinosis. Acta Med Scand 1985; 217: 3: 331-335.
23. Mayilyan K., Aivazyan V., Avetisyan G. et al. Families with positive history of schizophrenia: immunological and biochemical studies. Abstracts of Eighth World Congress on Psychiatric Genetics. Versailless 2000; 237.
24. Mayilyan K., Boyajyan A., Poghosyan A. et al. Immune system status in schizophrenia: family studies. Vestnik IAELPS 2001; 6: 42: 1: 117-120.
25. Mayilyan K., Poghosyan A.G. Anti brain-specific proteins and dopamine-β-monooxygenase autoantibodies in the blood of schizophrenic patients as well as healthy subjects with positive history of mentioned disease. Collection of Articles of the Young Researchers (ANAS) 2001; 2: 108-110.
26. Mayilyan K., Boyajyan A., Hakopyan S. et al. Complement system and circulating immune complexes under schizophrenia: family study. Schizophr Res 2003; 60: Suppl: 64-65.
27. Mayilyan K., Presanis J.S., Arnold J.N. et al. Complement mannan-binding lectin pathway initiator activity in schizophrenia. Molecular Immunol 2003; 40: 2-4: 201.
28. Melsom R.D., Smith P.R., Maini R.N. Demonstration of an unidentified 48 kD polypeptide in circulating immune complexes in rheumatoid arthritis. Ann Rheum Dis 1987; 46: 2: 104-108.
29. Mkrtchyan G., Hovsepyan M., Arakelyan A. et al. The studies of the indices of neuro-immune status in patients with FMF. Abstract of "Familial Mediterranean Fever" II. International Conference. Antalya 2000; 94.
30. Muller N., Riedel M., Hadjamu M. et al. Increase of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood-brain barrier permeability in schizophrenia. Am J Psychiat 1999; 156: 4: 634-636.
31. Nerurkar A.V., Advani S.H., Gothoskar B.P. Circulating immune complexes (CIC) in Hodgkin's disease. I. Levels and two-dimensional analysis. Neoplasma 1989; 36: 2: 199-204.
32. Nezlin R., Alarcon-Segovia D., Shoenfeld Y. Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus. J Autoimmun 1998; 11: 5: 489-493.
33. Nezlin R. A quantitative approach to the determination of antigen in immune complexes. J Immunol Methods 2000; 237: 1-16.
34. Nydeggar U.E. A place for soluble immune complexes in clinical immunology. Immunol Today 1985; 6: 3: 80-82.
35. Procaccia S., Lanzanova D., Caputo D. et al. Circulating immune complexes in serum and in cerebrospinal fluid of patients with multiple sclerosis. Characterization and correlation with the clinical course. Acta Neurol Scand 1988; 77: 5: 373-380.
36. Rodahl E., Iversen O.J. Analysis of circulating immune complexes from patients with ankylosing spondylitis by gel electrophoresis and immunoblotting using antiserum against a psoriasis associated retrovirus-like particle. Ann Rheum Dis 1986; 45: 11: 892-897.
37. Rothermundt M., Arolt V., Bayer T.A. Review of immunological and immunopathological findings in schizophrenia. Brain Behav Immun 2001; 15: 4: 319-339.
38. Shcherbakova I., Neshkova E., Dotsenko V. et at. The possible role of plasma kallikrein-kinin system and leukocyte elastase in pathogenesis of schizophrenia. Immunopharmacology 1999; 43: 2-3: 273-279.
39. Stefansdottir B., Kolka R., Gudnason V., Arason G.J. The effect of smoking on the formation and fate of immune comlexes. Molecular Immunol 2003; 40: 2-4: 201.
40. Suzuki Y., Gomez-Guerrero C., Shirato I. et al. Pre-existing glomerular immune complexes induce polymorphonuclear cell recruitment through an Fc receptor-dependent respiratory burst: potential role in the perpetuation of immune nephritis. J Immunol 2003; 170: 6: 3243-3253.
41. Tamarchenko I.P., Komarov V.T. Systemic lupus erythematosus and infectious endocarditis: similarities and differences. Ter Arkh 2002; 74: 4: 39-42.
42. Tereshchenko S.E., Riazanov S.L., Kotelevtsev Iu. V. et al. Relationship between the detection of circulating antibodies to antigen with a molecular weight of 67 kD and the severity of clinical manifestations of infectious-allergic myocarditis. Kardiologiia 1991; 31: 9: 19-20.
43. Traustadottir K.H., Sigfusson A., Steinsson K., Erlendsson K. C4A deficiency and elevated level of immune complexes: the mechanism behind increased susceptibility to systemic lupus erythematosus. J Rheumatol 2002; 29: 11: 2359-2366.
44. Voice J.K., Lachmann P.J. Neutrophil Fc gamma and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes. Eur J Immunol 1997; 27: 10: 2514-2523.
45. Voskuyl A.E., Hazes J.M., Zwinderman A.H. et al. Diagnostic strategy for the assessment of rheumatoid vasculitis. Ann Rheum Dis 2003; 62: 5: 407-413.
46. Wahren M., Ringertz N. R., Pettersson I. IgM and IgG subclass distribution of human anti-Ro/SSA 60 kDa autoantibodies. Scand J Immunol 1994; 39: 2: 179-182.
47. Wiederkehr F., Bueler M.R., Vonderschmilt D.J. Analysis of circulating immune complexes isolated from plasma, cerebrospinal fluid and urine. Electrophoresis 1991; 12: 7-8: 478-486.
48. Wiesmann M., Wandinger K.P., Missler U. et al. Elevated plasma levels of S-100b protein in schizophrenic patients. Biol Psychiat 1999; 45: 11: 1508-1511.
49. Zhen Q.Y., Walther S., Sodomann C.P. Small albumin-immunoglobulin complexes in patients with liver disease. Immunology 1983; 48: 4: 809-815.